Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CORPAY, INC.FLT · Entity 3172 | Director | January 24, 2022 | January 27, 2022 |
| Cardlytics, Inc.CDLX · Entity 7603 | Director | May 21, 2022 | May 25, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CORPAY, INC.
Report date January 24, 2022 · Filed January 27, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 85,966 |
Reported balance
After 2022-01-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-01-24 · Grant · Acquired 1,331 · Balance 85,966 F1: Restricted stock award for 2022 director service that vests 1/24/2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock award for 2022 director service that vests 1/24/2023.
Cardlytics, Inc.
Report date May 21, 2022 · Filed May 25, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,635 |
Reported balance
After 2022-05-21 transaction · row 1
1 source rowRow 1 · 2022-05-21 · Exercise / conversion · Acquired 1,701 · Balance 37,635 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-05-21 · Exercise / conversion · Disposed 1,701 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2: The RSUs vested in full on the one-year anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F2: The RSUs vested in full on the one-year anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2022 Filed May 25, 2022 00:52 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 1,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000072 · wf-form4_165343993887694.xml · derivative · entry 2 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant. F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant. Read SEC document |
| May 21, 2022 Filed May 25, 2022 00:52 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-22-000072 · wf-form4_165343993887694.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| January 24, 2022 Filed Jan 27, 2022 02:20 UTC | CORPAY, INC. FLT · Entity 3172 | GrantCommon Stock | 1,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-005132 · doc4.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,966 F1 · security: Restricted stock award for 2022 director service that vests 1/24/2023. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 00:44 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 2,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000129 · wf-form4_162276741910402.xml · derivative · entry 2 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,023 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant. F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 00:44 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 2,023 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-21-000129 · wf-form4_162276741910402.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| May 21, 2021 Filed May 27, 2021 23:00 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 1,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-21-000107 · wf-form4_162215639520070.xml · derivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,701 Underlying: Common Stock · 1,701 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 21:39 UTC | CORPAY, INC. FLT · Entity 3172 | GrantCommon Stock | 958 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-005675 · doc4.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,635 F1 · security: Restricted stock award for 2021 director service that vests 1/25/2022 Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 20:58 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 6,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000200 · wf-form4_159320509795807.xml · derivative · entry 2 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant. F2 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant. Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 20:58 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 6,353 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-20-000200 · wf-form4_159320509795807.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 22:19 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 2,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-20-000172 · wf-form4_159130916812896.xml · derivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,023 Underlying: Common Stock · 2,023 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 299 | $72.52 | $21,683.48 |
DisclosureSEC source: 0001666071-20-000146 · wf-form4_159019715924773.xml · nonDerivative · entry 12 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F7 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $72.515 to $72.55, inclusive. F8 · balance_after: Excludes 90,571 shares of common stock previously reported as owned by TTV Ivy Holdings, LLC ("TTV Ivy"), which were distributed to its limited partners on August 20, 2018. F9 · ownership.nature: The reportable securities are owned directly by TTV Ivy. The Reporting Person is a member of the general partner of TTV Ivy and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,112 | $71.43 | $79,430.16 |
DisclosureSEC source: 0001666071-20-000146 · wf-form4_159019715924773.xml · nonDerivative · entry 11 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 299 F6 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $71.02 to $71.75, inclusive. F8 · balance_after: Excludes 90,571 shares of common stock previously reported as owned by TTV Ivy Holdings, LLC ("TTV Ivy"), which were distributed to its limited partners on August 20, 2018. F9 · ownership.nature: The reportable securities are owned directly by TTV Ivy. The Reporting Person is a member of the general partner of TTV Ivy and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,212 | $70.44 | $85,373.28 |
DisclosureSEC source: 0001666071-20-000146 · wf-form4_159019715924773.xml · nonDerivative · entry 10 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,411 F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $70.02 to $71.00, inclusive. F8 · balance_after: Excludes 90,571 shares of common stock previously reported as owned by TTV Ivy Holdings, LLC ("TTV Ivy"), which were distributed to its limited partners on August 20, 2018. F9 · ownership.nature: The reportable securities are owned directly by TTV Ivy. The Reporting Person is a member of the general partner of TTV Ivy and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 684 | $68.35 | $46,751.40 |
DisclosureSEC source: 0001666071-20-000146 · wf-form4_159019715924773.xml · nonDerivative · entry 9 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,623 F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $68.285 to $68.95, inclusive. F8 · balance_after: Excludes 90,571 shares of common stock previously reported as owned by TTV Ivy Holdings, LLC ("TTV Ivy"), which were distributed to its limited partners on August 20, 2018. F9 · ownership.nature: The reportable securities are owned directly by TTV Ivy. The Reporting Person is a member of the general partner of TTV Ivy and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 864 | $67.87 | $58,639.68 |
DisclosureSEC source: 0001666071-20-000146 · wf-form4_159019715924773.xml · nonDerivative · entry 8 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,307 F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $67.29 to $68.265, inclusive. F8 · balance_after: Excludes 90,571 shares of common stock previously reported as owned by TTV Ivy Holdings, LLC ("TTV Ivy"), which were distributed to its limited partners on August 20, 2018. F9 · ownership.nature: The reportable securities are owned directly by TTV Ivy. The Reporting Person is a member of the general partner of TTV Ivy and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 628 | $66.62 | $41,837.36 |
DisclosureSEC source: 0001666071-20-000146 · wf-form4_159019715924773.xml · nonDerivative · entry 7 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,171 F1 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $66.29 to $67.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4), (5), (6) and (7) to this Form 4. F8 · balance_after: Excludes 90,571 shares of common stock previously reported as owned by TTV Ivy Holdings, LLC ("TTV Ivy"), which were distributed to its limited partners on August 20, 2018. F9 · ownership.nature: The reportable securities are owned directly by TTV Ivy. The Reporting Person is a member of the general partner of TTV Ivy and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,827 | $72.52 | $277,534.04 |
DisclosureSEC source: 0001666071-20-000146 · wf-form4_159019715924773.xml · nonDerivative · entry 6 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F7 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $72.515 to $72.55, inclusive. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 14,210 | $71.43 | $1,015,020.30 |
DisclosureSEC source: 0001666071-20-000146 · wf-form4_159019715924773.xml · nonDerivative · entry 5 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,827 F6 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $71.02 to $71.75, inclusive. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 15,488 | $70.44 | $1,090,974.72 |
DisclosureSEC source: 0001666071-20-000146 · wf-form4_159019715924773.xml · nonDerivative · entry 4 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 18,037 F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $70.02 to $71.00, inclusive. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 8,746 | $68.35 | $597,789.10 |
DisclosureSEC source: 0001666071-20-000146 · wf-form4_159019715924773.xml · nonDerivative · entry 3 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 33,525 F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $68.285 to $68.95, inclusive. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 11,048 | $67.87 | $749,827.76 |
DisclosureSEC source: 0001666071-20-000146 · wf-form4_159019715924773.xml · nonDerivative · entry 2 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 42,271 F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $67.29 to $68.265, inclusive. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:26 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 8,034 | $66.62 | $535,225.08 |
DisclosureSEC source: 0001666071-20-000146 · wf-form4_159019715924773.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 53,319 F1 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $66.29 to $67.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4), (5), (6) and (7) to this Form 4. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 19, 2020 Filed May 20, 2020 21:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 20,000 | $65.15 | $1,303,000.00 |
DisclosureSEC source: 0001666071-20-000136 · wf-form4_159000898138167.xml · nonDerivative · entry 4 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 61,353 F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.72, inclusive. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 19, 2020 Filed May 20, 2020 21:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 20,000 | $61.32 | $1,226,400.00 |
DisclosureSEC source: 0001666071-20-000136 · wf-form4_159000898138167.xml · nonDerivative · entry 3 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 81,353 F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.535, inclusive. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 19, 2020 Filed May 20, 2020 21:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 20,000 | $60.08 | $1,201,600.00 |
DisclosureSEC source: 0001666071-20-000136 · wf-form4_159000898138167.xml · nonDerivative · entry 2 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 101,353 F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $59.72 to $60.225, inclusive. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 18, 2020 Filed May 20, 2020 21:10 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 20,000 | $58.42 | $1,168,400.00 |
DisclosureSEC source: 0001666071-20-000136 · wf-form4_159000898138167.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 121,353 F1 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4) and (5) to this Form 4. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 15, 2020 Filed May 18, 2020 20:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,865 | $56.06 | $104,551.90 |
DisclosureSEC source: 0001666071-20-000134 · wf-form4_158983328965654.xml · nonDerivative · entry 4 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 141,353 F5 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.18, inclusive. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 15, 2020 Filed May 18, 2020 20:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 28,135 | $55.35 | $1,557,272.25 |
DisclosureSEC source: 0001666071-20-000134 · wf-form4_158983328965654.xml · nonDerivative · entry 3 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 143,218 F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.985, inclusive. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 14, 2020 Filed May 18, 2020 20:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 3,000 | $51.19 | $153,570.00 |
DisclosureSEC source: 0001666071-20-000134 · wf-form4_158983328965654.xml · nonDerivative · entry 2 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 171,353 F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $51.15 to $51.23, inclusive. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| May 14, 2020 Filed May 18, 2020 20:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 17,000 | $50.66 | $861,220.00 |
DisclosureSEC source: 0001666071-20-000134 · wf-form4_158983328965654.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 174,353 F1 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $50.10 to $51.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4) and (5) to this Form 4. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:32 UTC | CORPAY, INC. FLT · Entity 3172 | SaleCommon Stock | 15,000 | $321.33 | $4,819,995.00 |
DisclosureSEC source: 0001209191-20-011668 · doc4.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,677 Read SEC document |
| January 29, 2020 Filed Feb 1, 2020 00:36 UTC | CORPAY, INC. FLT · Entity 3172 | GrantCommon Stock | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-005880 · doc4.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,677 F1 · security: Restricted stock award for 2020 director service vests 1/1/2021 Read SEC document |
| September 13, 2019 Filed Sep 13, 2019 20:34 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 100,000 | $32.30 | $3,230,000.00 |
DisclosureSEC source: 0001666071-19-000111 · wf-form4_156840681747043.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 191,353 F1 · kind: Shares sold pursuant to the prospectus supplement dated September 10, 2019, to the prospectus dated August 29, 2019. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| June 25, 2019 Filed Jun 26, 2019 21:35 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Units · Derivative | 6,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-039152 · doc4.xml · derivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,353 Underlying: Common Stock · 6,353 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. F2 · derivative.expiration_date: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date. Read SEC document |
| March 09, 2019 Filed Apr 8, 2019 21:36 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Units · Derivative | 8,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-024019 · doc4.xml · derivative · entry 4 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,484 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F4 · derivative.exercise_date: The RSUs vested in full on the one-year anniversary of the date of grant. F4 · derivative.expiration_date: The RSUs vested in full on the one-year anniversary of the date of grant. Read SEC document |
| March 09, 2019 Filed Apr 8, 2019 21:36 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 8,484 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-024019 · doc4.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Read SEC document |
| January 22, 2019 Filed Mar 22, 2019 22:43 UTC | CORPAY, INC. FLT · Entity 3172 | GrantCommon Stock | 1,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021073 · doc4.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,894 F1 · security: Restricted stock award for 2019 director service vests 1/1/2020 Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 01:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | OtherWarrant (Right to Buy) · Derivative | 66,365 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046114 · doc4.xml · derivative · entry 6 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 66,365 shares Expires 2023-08-07 F1 · kind: The shares acquired upon exercise of the warrant were acquired through a net exercise procedure in accordance with the terms of the warrant and did not involve any sale of shares. F2 · ownership.nature: The reportable securities are owned directly by TTV Ivy Holdings, LLC ("TTV Ivy"). The Reporting Person is a member of the general partner of TTV Ivy and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 01:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionWarrant (Right to Buy) · Derivative | 13,273 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046114 · doc4.xml · derivative · entry 5 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,273 shares Expires 2023-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares acquired upon exercise of the warrant were acquired through a net exercise procedure in accordance with the terms of the warrant and did not involve any sale of shares. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 01:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | OtherCommon Stock | 66,365 | $0.00 | $26.55 |
DisclosureSEC source: 0001209191-18-046114 · doc4.xml · nonDerivative · entry 2 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 357,718 F1 · kind: The shares acquired upon exercise of the warrant were acquired through a net exercise procedure in accordance with the terms of the warrant and did not involve any sale of shares. F2 · ownership.nature: The reportable securities are owned directly by TTV Ivy Holdings, LLC ("TTV Ivy"). The Reporting Person is a member of the general partner of TTV Ivy and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 01:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 13,273 | $0.00 | $5.31 |
DisclosureSEC source: 0001209191-18-046114 · doc4.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares acquired upon exercise of the warrant were acquired through a net exercise procedure in accordance with the terms of the warrant and did not involve any sale of shares. Read SEC document |
| August 09, 2018 Filed Apr 8, 2019 21:29 UTC Amendment | Cardlytics, Inc. CDLX · Entity 7603 | OtherCommon Stock | 66,365 | $0.00 | $26.55 |
DisclosureSEC source: 0001209191-19-024015 · doc4a.xml · nonDerivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 95,370 F1 · kind: The shares acquired upon exercise of the warrant were acquired through a net exercise procedure in accordance with the terms of the warrant and did not involve any sale of shares. F2 · balance_after: This number was incorrectly calculated on the original Form 4. F3 · ownership.nature: The reportable securities are owned directly by TTV Ivy Holdings, LLC ("TTV Ivy"). The Reporting Person is a member of the general partner of TTV Ivy and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| August 07, 2018 Filed Aug 10, 2018 01:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | OtherWarrant (Right to Buy) · Derivative | 66,365 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046114 · doc4.xml · derivative · entry 4 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 66,365 Underlying: Common Stock · 66,365 shares Expires 2023-08-07 F3 · kind: The warrants were acquired pursuant to an agreement between the Reporting Person and the Issuer, dated May 4, 2017. The number of shares to be acquired (if any) upon exercise of the warrants could only be determined 180 days following the date of the Issuer's final prospectus relating to its initial public offering. F2 · ownership.nature: The reportable securities are owned directly by TTV Ivy Holdings, LLC ("TTV Ivy"). The Reporting Person is a member of the general partner of TTV Ivy and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| August 07, 2018 Filed Aug 10, 2018 01:28 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantWarrant (Right to Buy) · Derivative | 13,273 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046114 · doc4.xml · derivative · entry 3 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,273 Underlying: Common Stock · 13,273 shares Expires 2023-08-07 F3 · kind: The warrants were acquired pursuant to an agreement between the Reporting Person and the Issuer, dated May 4, 2017. The number of shares to be acquired (if any) upon exercise of the warrants could only be determined 180 days following the date of the Issuer's final prospectus relating to its initial public offering. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 20:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantRestricted Stock Unit · Derivative | 8,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019235 · doc4.xml · derivative · entry 1 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,484 Underlying: Common Stock · 8,484 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. F2 · derivative.exercise_date: The restricted stock units shall vest in full on the one-year anniversary of date of grant, provided that the Reporting Person (i) has served as a director for at least six months and (ii) remains a director of the Issuer on such vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest in full on the one-year anniversary of date of grant, provided that the Reporting Person (i) has served as a director for at least six months and (ii) remains a director of the Issuer on such vesting date. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 13:29 UTC | CORPAY, INC. FLT · Entity 3172 | GrantCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017898 · doc4.xml · nonDerivative · entry 2 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,618 F2 · security: Restricted stock award for 2018 director service vests 1/1/2019 Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | ConversionSeries G' Redeemable Convertible Preferred Stock · Derivative | 15,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010395 · doc4.xml · derivative · entry 12 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 15,045 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | ConversionSeries G Redeemable Convertible Preferred Stock · Derivative | 5,801 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010395 · doc4.xml · derivative · entry 11 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,801 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | ConversionSeries G Redeemable Convertible Preferred Stock · Derivative | 29,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010395 · doc4.xml · derivative · entry 10 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 29,005 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F3 · ownership.nature: The reportable securities are owned directly by TTV Ivy Holdings, LLC ("TTV Ivy"). The Reporting Person is a member of the general partner of TTV Ivy and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:23 UTC | Cardlytics, Inc. CDLX · Entity 7603 | ConversionSeries D-R Redeemable Convertible Preferred Sto · Derivative | 12,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010395 · doc4.xml · derivative · entry 9 JOHNSON MARK A · CIK 0001188623 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 12,291 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series B-R Redeemable Convertible Preferred Stock, Series C-R Redeemable Convertible Preferred Stock, Series D-R Redeemable Convertible Preferred Stock, Series G Redeemable Convertible Preferred Stock and Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F2 · ownership.nature: The reportable securities are owned directly by TTP Fund II L.P. ("TTP Fund") The Reporting Person is a member of the general partner of TTP Fund and a partner of TTV Capital, which provides management services to the general partner. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.